An understanding of the differences and similarities of the retinoid X receptor (RXR) and retinoic acid receptor (RAR) systems requires knowledge of the diversity of their family members, their patterns of expression, and their pharmacological response to ligands. In this paper we report the isolation of a family of mouse RXR genes encoding three distinct receptors (RXRa, p, and y). They are closely related to each other in their DNAand ligand-binding domains but are quite divergent from the RAR subfamily in both structure and ligand specificity. Recently, we demonstrated that all-trans retinoic acid (RA) serves as a "pro-hormone" to the isomer 9-cis RA, which is a high-affinity ligand for the human RXRa. We extend those findings to show that 9-cis RA is also "retinoid X" for mouse RXRa, p, and y. Trans-activation analyses show that although all three RXRs respond to a variety of endogenous retinoids, 9-cis RA is their most potent ligand and is up to 40-fold more active than all-trans RA. Northern blot and in situ hybridization analyses define a broad spectrum of expression for the RXRs, which display unique patterns and only partially overlap themselves and the RARs. This study suggests that the RXR family plays critical roles in diverse aspects of development, from embryo implantation to organogenesis and central nervous system differentiation, as well as in adult physiology.
Derivatives of vitamin A, or retinoids [e.g., retinoic acid (RA)], are a group of signaling molecules that are essential for several life processes including growth, differentiation, and epithelial homeostasis (Goodman 1984; Spom et al. 1984) . In the embryo, RA has also been implicated in many roles, including the formation of the developing nervous system (Dencker et al. 1987; Durston et al. 1989; Wagner et al. 1990 ), craniofacial differentiation (Wedden et al. 1988) , and limb morphogenesis (Maden 1982; Eichele 1989) . In contrast to the physiologic requirement of vitamin A for these processes, retinoids may be toxic or severely teratogenic when applied at high concentrations or at inappropriate times (Lammer et al. 1985) . The heterogeneity of these responses suggests the existence of complex signaling pathways to account for the diverse regulatory roles of retinoids. In the past several years, two distinct classes of nuclear hormone receptors were identified that mediate RA-dependent transcription. The first class is comprised of the RA receptors (RARa,p, and 7), all of which bind all-trans RA with high affinity and share a high degree of structural conservation (Giguere et al. 1987; Petkovich et al. ^Cotiesponding author.
1987; Brand et al. 1988; Krust et al. 1989; Zelent et al. 1989; Ishikawa et al. 1990 ). Recently, we described the existence of a second class of receptor that also responds to retinoids but is substantially different in primary structure and ligand specificity to the RARs . Because this new receptor, termed the retinoid X receptor (RXR), is activated by but does not bind to all-trans RA, we speculated that its ligand would be an RA metabolite.
The discovery in RXR of a second retinoid transduction pathway has led us to investigate its functional properties and determine its relationship to the RAR system. The initial observation that RXR is abundantly expressed in metabolic organs, such as the liver, kidney, and intestine, suggested a role for RXR in the regulation of vitamin A metabolism itself ). More recently, we have shown that a potent target for RXR action is the gene for cellular retinol-binding protein type II (CRBPII), a protein involved in the processing of dietary vitamin A in the intestine . The retinoid X response element (RXRE) found in the CRBPII gene promoter is strongly up-regulated by RXR but not by RAR. Furthermore, RXR activation through the CRBPII-RXRE can be completely inhibited by RAR. This interaction between RXR and RAR is made more intringuing by the recent finding that RXR can form stable solution heterodimers not only with RAR but also with vitamin D and thyroid hormone receptors (Kliewer et al. 1992 ). Thus, RXR may be a constituent in multiple hormonal signaling pathways. To better understand the complex functions of RXR, we have explored the diversity of the family, its patterns of expression, and its pharmacologic properties in response to ligand. In this paper we report the isolation of mouse cDNAs encoding three RXR proteins (mRXRa, 3, and y) . Each of these RXRs is expressed throughout development and in the mature organism in patterns that are both unique and partially overlap those of the RARs and other receptors. Recently, we demonstrated that the RA isomer, 9-cis RA, is a high-affinity ligand for the human RXRa (Heyman et al. 1992) . We extend those findings here to show that 9-cis RA is also "retinoid X" for the mouse RXRa, (3, and 7. The discovery of three RXRs and their cognate ligand, along with their patterns of expression, helps to define a complex new regulatory system in which the RXRs may play a surprisingly widespread role in development and adult physiology.
Results

Molecular cloning of three RXR cDNAs
We observed previously by low-stringency-hybridization Southern analysis of human genomic DNA that the RXR belongs to a subfamily of genes comprised of at least two members ). To isolate and characterize the mouse counterparts to these potential RXR subtypes, mouse adult liver and mouse embryo cDNA libraries were screened at low stringency with a human (h)RXRa cDNA probe. Several positive clones were analyzed and divided into three different groups based on their sequence identity. The longest cDNA clone from each group was completely sequenced (Fig. 1) . The three classes of cDNA clones encode three nonidentical RXRlike proteins designated mRXRa, mRXRp, and mRXR7 ( Figs. 1 and 2) . mRXRa is the murine homolog of the hRXRa ) with which it shares the greatest identity (Fig. 2) . The predicted initiation codon for mRXRa is conserved in the hRXRa and occurs at the first in-frame ATG of the cDNA (Fig. la) . The sequence surrounding this ATG conforms well with the Kozak consensus (Kozak 1987) , and translation from this start site generates an mRXRa protein of 467 amino acids (Mr 51,000). The sequence designated mRXRp (Fig.  lb) is also homologous to a human counterpart that we have partially characterized ; data not shown). Although we have tentatively assigned a translation initiation start site at nucleotide 109, there is no in-frame terminator codon upstream of this putative start site, indicating that the region encoding the amino terminus may yet have to be defined. We note, however, that this mRXRp cDNA will produce a functional protein (see Figs. 3 and 5, below) of 410 amino acids (Mr 44,000). Interestingly, the mRXRp cDNA characterized here is 100% identical in size and sequence to mH2RIIBP, a cDNA isolated independently by Hamada et al. (1989) , whose product binds a DNA site in the histocompatibility gene. The third receptor, mRXR7 (Fig. Ic) , appears to be most closely related to the chicken (c)RXR reported by Rowe et al. (1991) (Fig. 2) and a recently described Xenopus homolog (Blumberg et al. 1992) . The assigned initiation codon for mRXR-y is a canonical Kozak sequence with an in-frame termination site 12 bp upstream. The mRXR7 cDNA encodes a protein of 463 amino acids (M^ 51,000). The existence of RXRs in several species, including the related Drosophila protein ultiaspiracle (Fig. 2) (Oro et al. 1990 ), indicates that this gene family has been well conserved throughout evolution. As seen in Figure 2 , the RXRs comprise a closely related lineage with marked divergence from the RAR subfamily.
RXRs are activated by retinoids
The ability of all-trans RA to specifically activate the hRXRa demonstrated that this protein defined a pathway for retinoid action that was separate from the previously described RARs . Because all-trans RA activates both RARs and RXRs, transactivation experiments were performed in the Drosophila cell line Schneider S2, which unlike mammalian cells is devoid of endogenous retinoid receptors ). To examine the functional properties of each receptor subtype, expression plasmids containing the cDNAs for mRXRa, P, or 7 were cotransfected into cells together with a reporter plasmid (ADH-CRBPII-CAT) containing the RXRE from the CRBPII promoter . When these cells were incubated with increasing concentrations of alltrans RA, all three RXRs activated chloramphenicol acetyltransferase (CAT) expression (Fig. 3a) , albeit with distinctive pharmacologic properties. The potent efficacy of RXR activation by RA on the CRBPII-RXRE is demonstrated by mRXRp, which even though it is the least sensitive of the RXRs, gives a robust induction (85-fold) to all-trans RA.
We have also tested the response of the mRXRs to the vitamin A metabolite 3,4-didehydroretinoic acid (ddRA). In addition to all-trans RA, ddRA is a potent morphogenetic signal in the developing chick wing bud, where its concentration is six times greater than that of all-trans RA . As shown in Figure 3b , all three RXRs are responsive to ddRA, although at concentrations ~ 10-fold less than all-trans RA. We have observed similar results with the RARs (data not shown). These results indicate that although all-trans RA is a potent RXR activator, it is not the only biologically active retinoid that can stimulate the RXRs.
The RXR ligand-binding domain confers retinoid responsiveness
The activation of RXR by all-trans RA in insect cells (in comparison to mammalian cells. Fig. 3 ; Mangelsdorf et al. 1990) 
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transfer retinoid inducibility to another receptor. Previous studies have shown that this region of the steroid hormone receptors is the Hgand-binding domain (Evans 1988; Green and Chambon 1988) , supporting the proposal that RXR is a hormone-responsive receptor.
9-cis RA is a potent RXR ligand
Although zll-trans RA induces RXR in transfection assays, high concentrations are required. Furthermore, direct binding of all-trans RA to RXR protein synthesized in eukaryotic or bacterial cells has not been demonstrated (Heyman et al. 1992; D. Mangelsdorf, unpubl.) .
This led us to hypothesize that all-trans RA serves as a pro-hormone or metabolic precursor to a bona fide RXR ligand termed retinoid X. Recently, we have shown that for the hRXRa, one such retinoid X is 9-cis RA (Heyman et al. 1992) . This RA isomer is metabolically converted from all-trans RA in cells, exists in RXR target organs in vivo, and unlike all-trans RA binds RXRa protein with high affinity (Heyman et al. 1992 ). The results shown in Figure 5 provide evidence that 9-cis RA is also a ligand for each mouse RXR subtype. In these experiments, trans-activation by RXR of a luciferase reporter ADH-CRBPII-LUC was tested in the presence of the biologically active RA isomers all-trans RA, 13-cis RA, and 9-cJs RA. As with hRXRa, 9-cis RA was up to 40-fold more potent than either 13-cis or nil-trans RA in activating all three mRXRs. These responses were dose-dependent, saturable, and within the range of concentrations by which all-trans RA activates the RARs. These results support the proposal that 9-cis RA is a signaling molecule that can mediate its action through the RXRs. 
RXR expression in the adult
To understand the roles of the RXRs in hormonal signaling, we have examined their patterns of expression in the embryo and the adult. Northern analysis of poly(A)"^ RNA from adult male rat tissues reveals the presence of both unique and overlapping patterns of expression for the three RXR genes (Fig. 6a) . The rat RXRa mRNA migrates as a single species of 5.6 kb and displays the strongest level of expression for the RXRs in the adult. RXRa is noticeably abundant in visceral tissues such as the liver, kidney, lung, muscle, and spleen, but less so in adrenals, brain, heart, intestine, and testes (Fig. 6a, top) . The RXRp mRNA exists as two species of 2.7 and 3.0 kb. and both are relatively abundant in all tissues except intestine, liver, and testes where they are expressed at lower levels (Fig. 6a, middle) . In contrast to RXRa and RXR3, RXR-y RNA is less abundant and more restricted in its distribution. The complexity of this expression pattern is increased by the detection of two RXR7-specific RNAs (2.0 and 2.5 kb) that are also expressed differentially and may correspond to RXR-y isoforms, as has been observed with the RAR gene products (Giguere et al. 1990; Kastner et al. 1990 ). The 2.0-kb RXR7 mRNA is present in the adrenals, kidney, and liver, whereas the 2.5-kb RNA is present in the brain and lungs. In contrast, both mRNA isoforms are expressed strongly in the heart and muscle (Fig. 6a, bottom) . In aggregate, the RXRs are expressed in all adult tissues examined, with individual tissues showing selective overlap with RAR subtypes (e.g., see below). The skin is known to be a target organ for RA both therapeutically and during natural differentiation and a site of selective expression of RAR7. An analysis of the expression of the RXRs in adult human epidermis and keratinocytes (Fig. 7 ) reveals high levels of RXRa mRNA. A very faint band can be detected for RXRP, but even after a relatively long exposure there is no detectable signal for RXR7. These results suggest a combined and potentially interactive role for RXRa and RAR7 in human skin morphogenesis.
RXR expression during development
The critical requirement for RA during development has prompted a number of studies to explore the pattern of expression of the RARs and the cellular retinoid-binding proteins throughout embryogenesis (DoUe et al. 1989; Maden et al. 1989; Noji et al. 1989; Perez-Castro et al. 1989; Osumi-Yamashita et al. 1990; Ruberte et al. 1990; Smith and Eichele 1991) . Because it is clear that such studies must now take into account the RXRs, we have focused next on the pattern of expression of the three RXR genes during mouse embryogenesis. Northem analyses of whole-embryo mRNA reveal that all three RXRs are expressed from at least day 10.5 postconception to parturition (Fig. 6b) . As in the adult, RXRa and RXRp mRNAs are abundant, whereas RXR7 mRNA is present at much lower levels. Again, there is a heterogeneity in the distribution of the two RXR7 transcripts, with the larger 2.3-kb band being predominant in the early embryo, followed by a transition to a 1.9-kb transcript at embryonic day 15.5 ( Fig. 6b, bottom) .
In situ hybridization has been used to extend the findings of Northem blot hybridization and localize more specifically the developmental expression of the RXRs (Figs. 8-11) . A comparison on embryonic day 16.5 (E16.5) reveals a clear differential expression of the three RXR subtypes (Fig. 8) . The RXRa transcript is found predominantly in the epithelia of the digestive system, the skin, and the liver (Fig. 8a) . Expression is low in the central nervous system (CNS) and the skeleton. This pattern is found from the earliest stages of organogenesis through parturition (data not shown) and continues forward from newborn and adult (see Figs. 6a and 9a,b) . High RXRa signals are easily detected in the liver, the villi of the small intestine and epithelia of the colon, and the skin (Fig. 9a,b) . This pattern of expression supports the proposed role of RXRa in metabolism and retinoid physiology . Before ElO, we note intense hybridization signals present only in the extraembryonic tissue of the uterine wall (decidua), which can first be detected at E5 after implantation of the embryo (Fig. 9c) . Other preliminary data suggest that in subsequent stages before organogenesis there is also expression in the placenta.
In situ hybridization did not reveal a high degree of specificity for RXR^ transcription in the embryo, and in many cases the differences in signal intensity could not be distinguished from cell density (Fig. 8b) . However, in contrast to RXRa, there were significant levels of RXRp transcripts detected in the CNS. The widespread embryonic expression of RXRp is similar to that foimd in the adult (Fig. 6a) .
The RXR7 transcript displays the highest restriction of the three receptors (e.g.. Fig. 8c ). The intense hybridization signals seen at this stage are restricted to the corpus striatum (caudate putamen) and the pituitary, although weaker expression can also be detected in the neck and skeletal muscle, and tongue ( Fig. 10 a-c) . The high level of RXR7 expression in the striatum continues to be observed until at least 7 days after birth (data not shown). When the analysis of RXR7 is extended to earlier stages of development, the striking expression in the striatum could be identified as early as E13.5 (Fig. 1 la) and, in the pituitary anlage, as early as Ell (Fig. lib) . At these earlier stages (E10-E13), prominent high signals were also detected in the somites, which are precursors to skeletal muscle (Fig. 11 b-f) , and in the ventral horns of the spinal cord (Fig. llf) . In contrast to the RARs, prominent expression of any of the RXR subtypes was not observed in the developing limbs or skeletal system.
Discussion
The RXR Family
A striking observation to come from the original characterization of hRXRa was the apparent dissimilarity in
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Cold Spring Harbor Laboratory Press on October 19, 2017 -Published by genesdev.cshlp.org Downloaded from sequence to that of the RARs, providing evidence for an evolutionarily distinct retinoid-response pathway. An understanding of the differences and similarities of the RAR and RXR systems requires knowledge of the diversity of the family members, their patterns of expression, and their pharmacology in response to cognate ligands. In this paper we report the isolation of cDNAs encoding three mouse RXR proteins (mRXRa, p, and 7). These proteins are closely related to each other both in their DNA-binding and ligand-binding domains. Their homologies indicate that these receptors are likely to regulate common target sequences and respond to common ligands. However, they differ markedly in their aminoterminal domains, which could confer distinct trans-activation functions. Interestingly, although a Drosophila homolog of the RXR gene has been identified as the ultraspiiacle locus, there is no apparent insect homolog of the RARs (Oro et al. 1990 ). This indicates the ancient evolutionary origin of the RXRs and raises the question as to whether RXRs might represent the original retinoid signaling system. In this respect, it will be of interest to discover the ligand for ultiaspiiacle.
A novel signaling pathway
hRXRa was identified originally by its ability to respond to all-trans RA, and similarly, murine RXR subtypes are also activated by all-trans RA. However, the inability of RA to bind to in vitro-expressed RXR and the high doses of RA required in transfections for transcriptional activation led us to propose that this retinoid served as a metabolic precursor to a higher-affinity ligand. Recently, we demonstrated that 9-cis RA is a naturally occurring, high-affinity ligand for the hRXRa as determined by a combination of binding and activation studies (Heyman et al. 1992) . We also confirmed that all-trans RA shows no detectable binding affinity for RXRa. We extend those findings here to demonstrate that 9-cis RA is also retinoid X for the mouse RXRa, p, and 7 subtypes. Each of these receptors is activated by 9-cis RA with both increased potency and efficacy relative to all-trans RA. Although RXRs may interact with RARs (see below), they may also function independently. Expression in Drosophila Schneider cells is sufficient to reconstitute retinoid responsiveness. Thus, not only do the RXRs bind and respond to 9-cis RA but they are able to activate target genes in the absence of other RAR gene products. Furthermore, the RXRs are capable of activating through the recently described response element in the CRBPII gene that is not induced by the RARs . These results indicate that the RXRs are bona fide members of the nuclear receptor family and, together with the discovery of the new vertebrate hormone, 9-cis RA, define a second retinoid signaling pathway.
Tissue distribution
Although the RXRs can regulate distinct target genes from the RARs as described above, they may also regulate common target genes. The existence of three RARs and three RXRs that mediate the effects of the two retinoid hormones, all-trans RA and 9-cis RA, could help to account for the vast influence of retinoids on development and physiology. To understand the physiologic role of 9-cis RA, we have begun to analyze the target tissues for RXRs. In aggregate, in the adult organism, the RXRs are widely expressed. In general, for all the receptors, the adult pattern reflects a perdurance of that observed in situ in the embryo. Although there is no absolute correlation between the individual RAR and RXR subtypes, there are several interesting similarities. For example, both RARa and RXRp are found in almost all tissues. 
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whereas RARp and RAR7 and RXRa and RXR7 are much more restricted. Although RXRp shows no striking pattern, there is increased expression in the anterior extensions of the spinal cord and hind brain. RXRa shows abundant expression in liver, kidney, spleen, and a variety of visceral tissues that are in marked distinction to the RAR subtypes that are found in very low levels at these corresponding sites (Giguere et al. 1987; Brand et al. 1988; Zelent et al. 1989; Kastner et al. 1990 ). This pattern led us to propose that RXRa may be involved in retinoid and lipid metabolism, a hypothesis that was bolstered further by the demonstration that the CRBPII and apolipoprotein (apoAI) (Rottman et al. 1991) genes are RXR responsive. CRBPII helps to absorb dietary retinol and assist in its transfer to chylomicrons and ultimate transport to the liver. ApoAI is a major constituent of both chylomicrons and highdensity lipoproteins, which are known to play an important role in cholesterol metabolism. Because high levels of retinoids are teratogenic, especially to the early embryo, the abundant early expression of RXRa in the decidua and placenta may indicate that RXRa has a role in feedback regulation of retinoid uptake and storage in the embryo. The expression of RXRa in vital organs suggests an additional role for retinoids in physiologic homeostasis. Interestingly, RXRa and RAR7 are both expressed abundantly in the epidermis ( Fig. 7 ; Kastner et al. 1990 ), indicating that these two receptors are likely to be responsible for the dermatologic effects of retinoids.
The most restricted of the three receptors is RXR-^, which also shows a lower level of expression in the embryo and the adult. It is particularly common in the muscle and the brain. Thus, one might anticipate a role for RXR7 in aspects of muscle and CNS differentiation. In the chicken, a homolog of RXR7 has been shown to be expressed in the developing peripheral nervous system (Rowe et al. 1991) . The CNS pattern of RXR7 expression in the mouse is particularly interesting, showing prominence in the embryonic anlage to the caudate putamen (basal ganglia). This is the major target of dopaminergic irmervation by the substantia nigra. It is also the end site of impaired dopaminergic transmission found in Parkinsonian disorders (Yurek and Sladek 1990) . Because the neurons of the corpus striatum tend to be generated along distinct spatiotemporal gradients, it will be of interest to discover whether these gradients can be influenced by retinoids. Interestingly, both RXR7 and RARp are coexpressed in the motor neurons of the spinal cord, again suggesting a selective parity between these two receptor systems. We find prominent expression of RXR7 in the pituitary, suggesting a potential role for retinoids in the regulatory cascade associated with hypophyseal differentiation.
Family ties
It is generally believed that the nuclear receptors function as either homo-or heterodimers in binding to, and regulating expression of, target genes. Dimerization is apparently critical for high-affinity binding of receptor with its cognate hormone-response elements (Kumar and Chambon 1988) . Recent studies have shown that the binding sites for the vitamin D receptor (VDR), thyroid hormone receptor (TR), and RAR are closely related and comprise direct repeats spaced by 3, 4, or 5 nucleotides, respectively . This underlying relationship suggested a commonality in the way in which these receptors recognize target DNA. It is believed that for some receptors, including VDR, TR, and RAR, interaction with other nuclear factors is required for DNA binding (Glass et al. 1990; Liao et al. 1990; Darling et al. 1991; 0'Donnelletal. 1991; Yang etal. 1991) . It has been proposed that such nuclear factors may be members of the steroid receptor family such that DNA binding would be mediated by a heterodimeric complex (Glass et al. 1990 ). RXRa unexpectedly serves as a common heterodimeric partner for the VDR, TR, and RAR (Kliewer et al. 1992) . In vitro, each heterodimer displays cooperative binding to target DNA, suggesting that the interaction of the RXR with other receptors may yield a battery of factors with distinct functional properties. The range and diversity of effects that might be generated is augmented further by the existence of a, p, and y subtypes. Thus, the interaction of multiple RXR isoforms with other nuclear receptors responsive to their own array of ligands is likely to play a critical role in creating the high degree of diversity and specificity necessary to regulate a large network of hormone-responsive genes. Why the VDR, TR, and RAR interact with a common RXR partner is not yet clear, particularly as the actions of vitamin D and thyroid hormones are apparently not RA dependent. RXR may function independently of vitamin A in this role. Adding further to the complexity is the fact that RXR clearly displays activities on the CRBPII response element in the absence of any of these other three receptor types.
Perspectives
The identification of three distinct genes constituting the RXR subfamily, their patterns of expression, and their responsiveness to the newly characterized metabolite, 9-cis RA, provides the foundation for a much broader view for the role of retinoids in vertebrate development and physiology. The discovery in 1987 by Giguere et al. and Petkovich et al. of a human RAR offered the hope of analyzing the mechanisms of morphogenesis in a vertebrate system. This discovery was made more meaningful by the recognition that the RAR was a member of the steroid/thyroid hormone receptor superfamily. It was believed initially that this molecule might provide a single molecular mechanism to account for the diverse range of effects of RA in vertebrate development. This problem has obviously become much more complicated by the identification of the RAR and the RXR families, the identification of distinct and common target genes, and the exploitation of retinoid isomers as ligands. This daunting complexity has been augmented further by the suggestion that the RXRs may form additional partners with the vitamin D and thyroid hormone receptors, forcing a general re-evaluation of our current notions of signal transduction. Nonetheless, our evolving understanding of these molecular interactions provides us with a more comprehensive view of developmental and organ physiology and, most importantly, a fresh approach to the problem.
Materials and methods
Construction and screening of cDNA libraries
Subtype-specific mRXR cDNAs were isolated by screening an E16.5 mouse X.ZAPII cDNA library (for mRXRa), an adult mouse liver \gtll cDNA library (for mRXR3), and a El4.5 mouse XZAPII cDNA library (for mRXR7). The mouse liver cDNA library was a gift of J. Darnell (Rockefeller University); the mouse embryonic cDNA libraries were constructed in XZAPII (Stratagene) as described by Kakizuka et al. (1991) except that for the E16.5 library, cDNA inserts were size-selected to >4 kb. To isolate mRXRa and y cDNAs, the XZAPII libraries were screened at low stringency using the hRXRa cDNA as a probe ). To isolate mRXRp cDNA, the hRXRa probe was used to first isolate a human liver RXR^ cDNA , which was used subsequently to isolate mRXRp. All three mRXR cDNAs were excised or subcloned into the £coRI site of pBluescript (SK) vectors (Stratagene) and sequenced using double-stranded DNA template. The orientation of mRXRs in pSK is as follows: For mRXRa, the Kpnl site is toward the 5' end; for mRXRp, the Kpnl site is toward the 3' end; and for mRXR-y, the Kpnl site is toward the 5' end.
Plasmids
The reporter plasmids ADH-CRBPII-CAT and ADH-CRBPII-LUC contain CRBPII-RXRE inserted into position -33 of pD33-ADH-CAT ) or pD33-ADH-LUC (Heyman et al. 1992 ). These reporters contain the distal promoter of the Drosophila alcohol dehydrogenase gene linked to either the bacterial CAT gene (Krasnow et al. 1989) or the firefly luciferase gene (Heyman et al. 1992) . The A5C-RXR and A5C -USP expression plasmids were constructed by inserting the full coding region of each respective receptor into an expression vector containing the Drosophila actin 5c promoter ). The A5C expression plasmid for the RXR-USP chimeric receptor XXU (Fig. 4) was created by replacing the region encoding amino acids 224-462 of hRXRa ) with the region encoding amino acids 190-508 of USP (Oro et al. 1990 ). Similarly, A5C-UUX was created by replacing the region encoding amino acids 188-508 of USP with the region encoding amino acids 221-462 of hRXRa. The poinds of fusion between RXR and USP were generated by PCR-directed site mutagenesis and confirmed by sequencing.
Cotransfection assays
Schneider line S2 cell culture, transfections, and CAT assays were performed as described previously ). Transfection of plasmid DNAs into S2 cells (Figs. 3 and 4) was accomplished in duplicate in 6-well (35-mm^/well) tissue culture plates. The amount of plasmids (in | jLg) cotransfected per well was 1 : 0.5 : 0.5 : 8 (A5C-RXR/ADH-CRBPII-CAT/A5C-Pgal: pGEM4 carrier). Cotransfection assays with the luciferase reporters (Fig. 5) were performed as described previously (Heyman et al. 1992 ) using Biomek (Beckman) automated work stations. Stock concentrations of all-trans RA (Sigma), ddRA (gift of Gregor Eichele), or the cis isomers of RA (Heyman et al. 1992) were made up in ethanol or dimethylsulfoxide solvents and delivered to cells at 10^-fold dilutions [0.1% (vol/vol) of solvent in media]. The characterization and synthesis of pure RA isomers has been described (Heyman et al. 1992) . Transfections in which the control expression plasmid A5C-RXRrev ) was substituted for A5C-RXR showed no activation at any ligand concentration (data not shown). Differences in the activation profiles shown in Figures 3 and 5 are the result of the inherent differences in the activation properties of the CAT and luciferase reporter plasmids and cannot be compared directly.
RNA preparation and Northern analyses
Murine poly(A)"^ RNA used in these studies was derived from fresh tissue, as described previously ).
Northern blot gels and hybridizations using murine RNA were performed as detailed elsewhere ). Equal amounts (10 \x,g] of poly(A)'^ RNA represented in each lane (Fig.  6 ) were verified by ethidium bromide staining and hybridizations performed with an actin cDNA probe as a control (data not shown). The human skin RNA blot (Fig. 7) was obtained from Gary Fisher (Department of Dermatology, University of Michigan, Ann Arbor). Northern hybridizations were performed on the same blots for each receptor by sequential hybridization and stripping of each RXR probe. In each case, the probes used were the entire JScoRI insert of RXRa, RXRp, or RXR7.
In situ hybridization analyses
Antisense RNA probes labeled with [a-^^S]UTP (1000-1500 Ci/ mmole, NEN) were generated with T3 or T7 polymerase from linearized pSK-mRXRs according to the manufacturer (Stratagene). For pSK-mRXRa, Xhol and T3 polymerase were used; for pSK-mRXR3, Notl and T7 polymerase; and for pSK-mRXR7, Asp718 and T3 polymerase. Synthesized probes were purified by separating free nucleotides with a Sephadex spun column followed by ethanol precipitation. Probes of average size 300 bp were generated by partial alkaline hydrolysis. The in situ hybridizations were performed as described by Bettler et al. (1990) . Specificity of the signals was verified by using unrelated probes and by using probes from nonoverlapping subclones. The sections were exposed to Hyperfilm Betamax (Amersham) for 10 days. Some sections were dipped for higher resolution in Kodak NTB-2 emulsion, developed after 4 weeks, and stained with Giemsa. Embryos and neonatal mice obtained from matings between ICR mice (HSD) were collected at the stages described. The occurrence of a vaginal plug was defined as EO and the day of birth as PO. Morphological structures were identified by reference to Rugh (1990) and Theiler (1989) .
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